Cargando…
Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin
BACKGROUND: Guillain-Barré syndrome (GBS) is an autoimmune condition characterized by peripheral neuropathy. The pathogenesis of GBS is not fully understood, and the mechanism of how intravenous immunoglobulin (IVIG) cures GBS is ambiguous. Herein, we investigated lymphocyte subsets in patients with...
Autores principales: | Hou, Hui Qing, Miao, Jun, Feng, Xue Dan, Han, Mei, Song, Xiu Juan, Guo, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210538/ https://www.ncbi.nlm.nih.gov/pubmed/25315010 http://dx.doi.org/10.1186/s12883-014-0202-3 |
Ejemplares similares
-
T-lymphocyte subset abnormalities in the Guillain-Barré syndrome
por: Dahle, C., et al.
Publicado: (1994) -
Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
por: Rajabally, Yusuf A.
Publicado: (2022) -
Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011) -
Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009) -
Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
por: Garcia, Jao Jarro, et al.
Publicado: (2021)